Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing isosorbide mononitrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
|
Isosorbide mononitrate adverse reaction |
Causative agent |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Modified release isosorbide mononitrate adverse reaction |
Causative agent |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
allergi over for isosorbidmononitrat |
Causative agent |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
|
allergi over for isosorbidmononitrat med modificeret frigivelse |
Causative agent |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
|
Isosorbide mononitrate overdose |
Causative agent |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
isosorbidmononitrat kapsel med modificeret udløsning a 60 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
|
isosorbidmononitrat kapsel med modificeret udløsning a 40 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
|
isosorbidmononitrat 25 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
|
isosorbidmononitrat 50 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
|
isosorbidmononitrat kapsel med modificeret udløsning a 50 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
|
isosorbidmononitrat 40 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
|
isosorbidmononitrat kapsel med modificeret udløsning a 25 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
|
Isosorbide mononitrate 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
|
Isosorbide mononitrate 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
|
Isosorbide mononitrate 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
|
isosorbidmononitrat 60 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
|
Product containing aspirin and isosorbide mononitrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
|
isosorbidmononitrat 60 mg + aspirin 150 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
|
isosorbidmononitrat 60 mg + aspirin 75 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
|
isosorbidmononitrat med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
|
isosorbidmononitrat 300 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
|
isosorbidmononitrat 120 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
|
allergi over for isosorbidmononitrat |
Causative agent |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
allergi over for isosorbidmononitrat med modificeret frigivelse |
Causative agent |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide mononitrate 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide mononitrate 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide mononitrate 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide mononitrate 20 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide mononitrate 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide mononitrate 40 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide mononitrate 30mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
|
Isosorbide mononitrate 120mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
|
Product containing precisely isosorbide mononitrate 60 milligram/1 each prolonged-release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isosorbide mononitrate 60 milligram/1 each prolonged-release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide mononitrate 25 mg prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide mononitrate 25 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isosorbide mononitrate 25 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isosorbide mononitrate 25 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide mononitrate 50 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide mononitrate 50 mg prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide mononitrate 50 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide mononitrate 50 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isosorbide mononitrate 40 milligram/1 each prolonged-release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isosorbide mononitrate 40 milligram/1 each prolonged-release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isosorbide mononitrate 60 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isosorbide mononitrate 60 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide mononitrate 40 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide mononitrate 40 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide mononitrate 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide mononitrate 20 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide mononitrate 40 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide mononitrate 30 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide mononitrate 30 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing isosorbide mononitrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide mononitrate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing only isosorbide mononitrate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing isosorbide mononitrate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing aspirin and isosorbide mononitrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |
Aspirin and isosorbide mononitrate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isosorbide mononitrate (substance) |
Inferred relationship |
Some |
1 |